Skip to content

Clinical Study of Qingfei Litan Decoction on Airway Mucus Hypersecretion in Stable Bronchiectasis

Clinical Study of Qingfei Litan Decoction on Airway Mucus Hypersecretion in Stable Bronchiectasis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006062
Enrollment
Unknown
Registered
2022-06-04
Start date
2022-05-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Mucus Hypersecretion in Bronchiectasis

Interventions

test group:Qingfei Litan Decoction
Control group:Carboxymestane Oral Liquid

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Outpatients who met the diagnostic criteria for stable bronchiectasis;(2)o smoking within 1 year prior to enrollment, sputum >30 ml per day, and no acute exacerbations due to medical history and physical examination; (3) Aged 18-75 years; (4)TCM syndrome differentiation is phlegm and heat accumulation,Spleen and kidney deficiency; (5) Patients who have at least 3 acute exacerbations in the past year; (6) Those who are willing to follow the doctor's diagnosis and treatment arrangements and sign informed consent.

Exclusion criteria

Exclusion criteria: (1)Patients with dry bronchitis as the main manifestation of hemoptysis; (2) Those who have changed their condition within 4 weeks before enrollment;(3)Patients with severe hematopoietic system diseases, advanced malignant tumors, severe liver and kidney dysfunction;(4)Other circumstances that the investigator considers unfit for inclusion.

Design outcomes

Primary

MeasureTime frame
CASA-Q score;24-hour sputum volume;

Secondary

MeasureTime frame
Mucin 5AC;Pulmonary function;Neutrophil elastase;erythrocyte sedimentation rate;Quantitative symptom score;tumor marke;Chest CT scan;C-reactive protein;The number of acute exacerbations of bronchiectasis;

Countries

China

Contacts

Public ContactWang Bing

Xiyuan Hospital, China Academy of Chinese Medical Sciences

angeline1019@126.com+86 13426459995

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026